The Bio-Hub Agenda involves the collaboration of four promoters (2 companies and 2 Research and Technology Organizations), which complement each other to the extent that their activities are at different stages of the value chain of biopharmaceutical development.
The symbiosis between the four promoters, LxBio, Technophage, VectorB2B and Faculdade de Farmácia-Universidade de Lisboa, is fundamental for the success of the Innovation Agenda.
The Consortium Promoters
The Bio-Hub Innovation Agenda will be led by the LxBio a company which has revealed all the technical capabilities essential to its leadership, since the development to the implementation phases of the project. As a promoter, Lx Bio will be responsible for the entire process of financing and managing the construction/qualification of the production unit for the development of biopharmaceuticals products.
Technophage has a strong scientific and management team, with training mainly in the areas of Biomedicine, Pharmacy, and Drug Development. It has gathered know-how in the pharmaceutical sector, over the last few years, as a result of various projects developed, of which the TP-102 study (Research and Development of new therapeutic products with antibacterial activity for the treatment and prevention of bacterial infections of diabetic foot ulcers, with a view to complementing classical antibiotic therapy of chemical origin) and TP-122 (Research and Development of a phage-based technology as therapy and prevention for bacterial lung infections).
VectorB2B is a CoLab (Collaborative Laboratory) founded in 2019 and constituted by a renowned set of academic and industrial partners within the Portuguese Health Sector (Faculty of Pharmacy of the University of Lisbon, Faculty of Medicine of the University of Lisbon, Faculty of Veterinary Medicine of the University of Lisbon, University of Coimbra, Medinfar, BeVaG and Technophage); beside an internal clinical research team. VectorB2B gathers the different expertise and capacities to provide customized and integrated solutions from the bench to bedside (B2B).
Faculty of Pharmacy, Universidade de Lisboa
Founded in 1836, Faculty of Pharmacy, Universidade de Lisboa (FFUL) is currently among the most prestigious institutions of higher education in the country and has also been focused on the international panorama. In addition to its high-quality educational activity, FFUL today plays a major role in the context of national and international scientific activity. Over the years, it has been positioning itself to attract external investment for R&D projects, in various scientific areas and in a broad spectrum of typologies, both as a promoter and partner, which translates into a diversified portfolio of projects.